| Dr Christiaan Erik De Vries, MD | |
|
5301 Virginia Way, Suite 300, Brentwood, TN 37027-7541 | |
| (615) 695-4977 | |
| (615) 263-3348 |
| Full Name | Dr Christiaan Erik De Vries |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 16 Years |
| Location | 5301 Virginia Way, Brentwood, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528349669 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dupont Hospital Llc | Fort wayne, IN | Hospital |
| Adams Memorial Hospital | Decatur, IN | Hospital |
| Lutheran Hospital Of Indiana | Fort wayne, IN | Hospital |
| Kosciusko Community Hospital | Warsaw, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associated Pathologists Llc | 0648167544 | 103 |
News Archive
Results of a first-of-its-kind clinical trial shed light on when antibiotics instead of surgery might be the better choice for treating appendicitis in some patients, according to researchers with The University of Texas Health Science Center at Houston, who led the Houston trial sites.
Kidneys from deceased donors with hepatitis C virus (HCV) infection can be safely transplanted into noninfected recipients when a regimen of direct-acting antiviral therapies is initiated as early as two days after the transplant, according to a study from Massachusetts General Hospital (MGH).
A new study by researchers in Cleveland Clinic's Taussig Cancer Institute and Lerner Research Institute describes a novel class of targeted cancer drugs that may prove effective in treating certain common types of leukemia.
A team of UNC scientists has received a five-year $2,308,800 grant from the National Cancer Institute's Cancer Nanotechnology Platform Partnerships to address the critical need for early diagnosis of and more effective treatments for pancreatic cancer.
Today clinicians from around the world will gather at the 4th Brainlab European Radiotherapy User Meeting to share their best practice and experiences in treating difficult-to-treat cancers using advanced radiotherapy.
› Verified 7 days ago
| Entity Name | Northeast Indiana Urology. P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619920295 PECOS PAC ID: 5395641914 Enrollment ID: O20031212000174 |
News Archive
Results of a first-of-its-kind clinical trial shed light on when antibiotics instead of surgery might be the better choice for treating appendicitis in some patients, according to researchers with The University of Texas Health Science Center at Houston, who led the Houston trial sites.
Kidneys from deceased donors with hepatitis C virus (HCV) infection can be safely transplanted into noninfected recipients when a regimen of direct-acting antiviral therapies is initiated as early as two days after the transplant, according to a study from Massachusetts General Hospital (MGH).
A new study by researchers in Cleveland Clinic's Taussig Cancer Institute and Lerner Research Institute describes a novel class of targeted cancer drugs that may prove effective in treating certain common types of leukemia.
A team of UNC scientists has received a five-year $2,308,800 grant from the National Cancer Institute's Cancer Nanotechnology Platform Partnerships to address the critical need for early diagnosis of and more effective treatments for pancreatic cancer.
Today clinicians from around the world will gather at the 4th Brainlab European Radiotherapy User Meeting to share their best practice and experiences in treating difficult-to-treat cancers using advanced radiotherapy.
› Verified 7 days ago
| Entity Name | Associated Pathologists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003863580 PECOS PAC ID: 0648167544 Enrollment ID: O20070716000207 |
News Archive
Results of a first-of-its-kind clinical trial shed light on when antibiotics instead of surgery might be the better choice for treating appendicitis in some patients, according to researchers with The University of Texas Health Science Center at Houston, who led the Houston trial sites.
Kidneys from deceased donors with hepatitis C virus (HCV) infection can be safely transplanted into noninfected recipients when a regimen of direct-acting antiviral therapies is initiated as early as two days after the transplant, according to a study from Massachusetts General Hospital (MGH).
A new study by researchers in Cleveland Clinic's Taussig Cancer Institute and Lerner Research Institute describes a novel class of targeted cancer drugs that may prove effective in treating certain common types of leukemia.
A team of UNC scientists has received a five-year $2,308,800 grant from the National Cancer Institute's Cancer Nanotechnology Platform Partnerships to address the critical need for early diagnosis of and more effective treatments for pancreatic cancer.
Today clinicians from around the world will gather at the 4th Brainlab European Radiotherapy User Meeting to share their best practice and experiences in treating difficult-to-treat cancers using advanced radiotherapy.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christiaan Erik De Vries, MD 5301 Virginia Way, Suite 300, Brentwood, TN 37027-7541 Ph: (615) 695-4977 | Dr Christiaan Erik De Vries, MD 5301 Virginia Way, Suite 300, Brentwood, TN 37027-7541 Ph: (615) 695-4977 |
News Archive
Results of a first-of-its-kind clinical trial shed light on when antibiotics instead of surgery might be the better choice for treating appendicitis in some patients, according to researchers with The University of Texas Health Science Center at Houston, who led the Houston trial sites.
Kidneys from deceased donors with hepatitis C virus (HCV) infection can be safely transplanted into noninfected recipients when a regimen of direct-acting antiviral therapies is initiated as early as two days after the transplant, according to a study from Massachusetts General Hospital (MGH).
A new study by researchers in Cleveland Clinic's Taussig Cancer Institute and Lerner Research Institute describes a novel class of targeted cancer drugs that may prove effective in treating certain common types of leukemia.
A team of UNC scientists has received a five-year $2,308,800 grant from the National Cancer Institute's Cancer Nanotechnology Platform Partnerships to address the critical need for early diagnosis of and more effective treatments for pancreatic cancer.
Today clinicians from around the world will gather at the 4th Brainlab European Radiotherapy User Meeting to share their best practice and experiences in treating difficult-to-treat cancers using advanced radiotherapy.
› Verified 7 days ago
Kathy Bruner, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5301 Virginia Way, Suite 300, Brentwood, TN 37027 Phone: 615-221-4474 Fax: 615-234-3774 | |
Kenneth S Piech, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 5301 Virginia Way, Ste 300, Brentwood, TN 37027 Phone: 615-221-4474 Fax: 615-234-3774 | |
Roy W. Kirchberg Jr., M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 5301 Virginia Way, Ste 300, Brentwood, TN 37027 Phone: 615-221-4474 Fax: 615-234-3774 | |
Dr. Lori D Emerson, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5301 Virginia Way, Suite 300, Brentwood, TN 37027 Phone: 615-695-4977 | |
Ben W Davis, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 5301 Virginia Way Ste 300, Brentwood, TN 37027 Phone: 615-221-4474 Fax: 615-234-3774 | |
Randall L Woodford, MD Pathology Medicare: Medicare Enrolled Practice Location: 5301 Virginia Way, 300, Brentwood, TN 37027 Phone: 615-221-4474 Fax: 615-234-3774 | |
Dr. Soheila Yadrandji, MD Pathology Medicare: Medicare Enrolled Practice Location: 5301 Virginia Way, Suite 300, Brentwood, TN 37027 Phone: 615-221-4474 Fax: 615-234-3774 |